Arrowhead Pharmaceuticals, Inc. (ARWR): Price and Financial Metrics

ARWR POWR Grades

• ARWR scores best on the Value dimension, with a Value rank ahead of 72.38% of US stocks.
• The strongest trend for ARWR is in Growth, which has been heading up over the past 177 days.
• ARWR ranks lowest in Stability; there it ranks in the 16th percentile.

ARWR Stock Summary

• ARWR's price/sales ratio is 14.5; that's higher than the P/S ratio of 92.08% of US stocks.
• With a year-over-year growth in debt of 219.34%, ARROWHEAD PHARMACEUTICALS INC's debt growth rate surpasses 93.51% of about US stocks.
• Revenue growth over the past 12 months for ARROWHEAD PHARMACEUTICALS INC comes in at 75.89%, a number that bests 88.76% of the US stocks we're tracking.
• If you're looking for stocks that are quantitatively similar to ARROWHEAD PHARMACEUTICALS INC, a group of peers worth examining would be AVIR, ALLO, TSP, INDI, and INMB.
• ARWR's SEC filings can be seen here. And to visit ARROWHEAD PHARMACEUTICALS INC's official web site, go to arrowheadpharma.com.

ARWR Valuation Summary

• ARWR's price/sales ratio is 14.7; this is 617.07% higher than that of the median Healthcare stock.
• Over the past 226 months, ARWR's price/earnings ratio has gone NA NA.

Below are key valuation metrics over time for ARWR.

ARWR Growth Metrics

Its 4 year net income to common stockholders growth rate is now at 115.95%.
• Its 2 year net income to common stockholders growth rate is now at -1273.02%.
• The 2 year revenue growth rate now stands at 89.55%.

Over the past 33 months, ARWR's revenue has gone up $79,638,740.

The table below shows ARWR's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	243.231	-136.131	-176.063
2022-06-30	249.939	-91.581	-153.926
2022-03-31	263.418	-52.344	-111.804
2021-12-31	144.424	148.799	-182.988
2021-09-30	138.287	171.224	-140.848
2021-06-30	107.6379	184.491	-125.9067

ARWR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ARWR has a Quality Grade of C, ranking ahead of 55.82% of graded US stocks.
• ARWR's asset turnover comes in at 0.171 -- ranking 211th of 682 Pharmaceutical Products stocks.
• COLL, CRBP, and VBIV are the stocks whose asset turnover ratios are most correlated with ARWR.

The table below shows ARWR's key quality metrics over time.